UC96:LSE:LSE-UBS (Irl) ETF plc - Factor MSCI USA Prime Value ESG UCITS ETF (USD) A-dis GBP (GBX)

ETF | Others |

Last Closing

USD 2871

Change

0.00 (0.00)%

Market Cap

USD 0.17B

Volume

230.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 510.38B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 510.38B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 210.67B
0QZ3:LSE Qualcomm Inc.

N/A

USD 202.26B

ETFs Containing UC96:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.02% 59% D- 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.02% 59% D- 60% D-
Trailing 12 Months  
Capital Gain 21.92% 57% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.92% 57% F 59% D-
Trailing 5 Years  
Capital Gain 68.51% 76% C+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 68.51% 76% C+ 75% C
Average Annual (5 Year Horizon)  
Capital Gain 11.59% 70% C- 72% C
Dividend Return 11.59% 70% C- 71% C-
Total Return 0.00% 17% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 9.92% 67% D+ 81% B-
Risk Adjusted Return 116.87% 98% N/A 99% N/A
Market Capitalization 0.17B 58% F 33% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.